Skip to main content
logo
Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
84.49
+1.39 (1.67%)
Jan 15, 2026, 4:00 PM EST - Market closed

Edwards Lifesciences Revenue by Segment

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Transcatheter Aortic Valve Replacement
4.36B4.24B4.14B4.11B4.05B3.99B3.94B3.88B
Transcatheter Aortic Valve Replacement Growth
7.77%6.28%5.20%5.83%7.46%8.65%9.90%10.28%
Surgical Structural Heard
986.60M968.60M966.10M981.30M1.02B1.03B1.02B999.30M
Surgical Structural Heard Growth
-3.14%-5.52%-5.02%-1.80%4.45%8.11%10.51%11.89%
Critical Care
------957.50M928.10M902.60M888.90M864.80M855.00M841.60M847.00M
Critical Care Growth
------10.72%8.55%7.25%4.95%1.57%2.41%2.45%7.26%
Transcatheter Mitral and Tricuspid Therapies
500.00M445.90M394.40M352.10M303.00M264.30M228.90M197.60M
Transcatheter Mitral and Tricuspid Therapies Growth
65.02%68.71%72.30%78.19%75.04%75.73%75.13%70.20%

Revenue by Geography

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
United States
3.28B3.18B3.10B3.21B3.46B3.52B3.60B3.51B
United States Growth
-5.11%-9.79%-13.78%-8.63%1.37%5.86%11.39%12.01%
Europe
1.41B1.34B1.30B1.32B1.37B1.37B1.37B1.33B
Europe Growth
2.80%-2.36%-5.51%-0.96%6.85%11.59%14.76%13.59%
Rest of World
585.20M566.20M543.30M572.00M656.40M688.10M722.80M709.20M
Rest of World Growth
-10.85%-17.72%-24.83%-19.35%-3.09%5.05%16.28%17.92%
Japan
327.40M318.70M310.80M339.80M391.60M418.60M449.10M452.40M
Japan Growth
-16.39%-23.87%-30.79%-24.89%-13.27%-6.40%-0.69%-4.48%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.